Theodore E. Liston
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 5
- Inflammatory mediators and NSAID effects 5
- Antibiotics Pharmacokinetics and Efficacy 4
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 5
- Inflammatory mediators and NSAID effects 5
- Antibiotics Pharmacokinetics and Efficacy 4
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 5
-
- Computational Drug Discovery Methods 3
-
- Adenosine and Purinergic Signaling 7
-
- Metabolomics and Mass Spectrometry Studies 3
- Co-authors
- David J. RanceJames G. BaxterB. Michael SilberPhilip WastallB. JonesFiona MacintyreR. Scott ObachBarry Jones
- Journals
- Stroke (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Theodore E. Liston
29 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Pharmacology 636
- Pharmacology 408
- Molecular Medicine 107
- Oncology 526
- Computational Theory and Mathematics 280
Countries citing papers authored by Theodore E. Liston
This map shows the geographic impact of Theodore E. Liston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore E. Liston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore E. Liston more than expected).
Fields of papers citing papers by Theodore E. Liston
This network shows the impact of papers produced by Theodore E. Liston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore E. Liston. The network helps show where Theodore E. Liston may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Theodore E. Liston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 23 | |
| 5 | 2021 | 16 | |
| 6 | 2020 | 19 | |
| 7 | 2011 | 114 | |
| 8 | 2011 | 186 | |
| 9 | 2008 | 22 | |
| 10 | 2001 | 73 | |
| 11 | 1998 | 4 | |
| 12 | 1998 | 15 | |
| 13 | 1996 | 46 | |
| 14 | 1996 | 63 | |
| 15 | 1996 | 47 | |
| 16 | 1996 | 63 | |
| 17 | 1995 | 85 | |
| 18 | 1987 | 5 | |
| 19 | 1987 | 11 | |
| 20 | PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery rings. | 1987 | 8 |
About Theodore E. Liston
Theodore E. Liston is a scholar working on Physiology, Pharmacology, Molecular Medicine, Pharmacology and Neurology, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (7 papers), Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Inflammatory mediators and NSAID effects (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Computational Drug Discovery Methods (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Pharmacology (636 citations), Pharmacology (408 citations), Molecular Medicine (107 citations), Oncology (526 citations) and Computational Theory and Mathematics (280 citations). Theodore E. Liston has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include David J. Rance, James G. Baxter, B. Michael Silber, Philip Wastall, B. Jones, Fiona Macintyre, R. Scott Obach, Barry Jones, Lisa Roberts and Renli Teng. Their work appears in journals such as Stroke, Journal of Antimicrobial Chemotherapy, Journal of Pharmaceutical Sciences, Clinical Infectious Diseases and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.